ChemPartner PharmaTech Co Ltd (300149) — Net Asset Momentum
ChemPartner PharmaTech Co Ltd (300149) recorded a net asset momentum of 5.0% as of December 2025, with net assets of CN¥1.30 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See how many days can ChemPartner PharmaTech Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
ChemPartner PharmaTech Co Ltd Net Asset Momentum (2007–2025)
This chart tracks ChemPartner PharmaTech Co Ltd's year-over-year net asset growth across 19 annual reporting periods from 2007 to 2025. The most recent momentum reading is +5.0%, with net assets of CN¥1.30 Billion CNY as of December 2025. Read 300149 current and long-term liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for ChemPartner PharmaTech Co Ltd (2007–2025)
The table below shows the complete annual net asset history for ChemPartner PharmaTech Co Ltd from 2007 to 2025, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see ChemPartner PharmaTech Co Ltd stock valuation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.30 Billion | CN¥2.03 Billion | CN¥732.59 Million | ▲ +5.0% |
| 2024 | CN¥1.24 Billion | CN¥2.00 Billion | CN¥757.75 Million | ▼ -15.3% |
| 2023 | CN¥1.46 Billion | CN¥2.43 Billion | CN¥973.44 Million | ▼ -38.8% |
| 2022 | CN¥2.39 Billion | CN¥3.82 Billion | CN¥1.44 Billion | ▲ +20.0% |
| 2021 | CN¥1.99 Billion | CN¥4.22 Billion | CN¥2.23 Billion | ▼ -18.9% |
| 2020 | CN¥2.45 Billion | CN¥4.12 Billion | CN¥1.67 Billion | ▲ +6.5% |
| 2019 | CN¥2.30 Billion | CN¥3.77 Billion | CN¥1.46 Billion | ▲ +4.5% |
| 2018 | CN¥2.20 Billion | CN¥3.35 Billion | CN¥1.14 Billion | ▲ +163.9% |
| 2017 | CN¥835.45 Million | CN¥1.04 Billion | CN¥207.73 Million | ▲ +8.5% |
| 2016 | CN¥769.93 Million | CN¥793.16 Million | CN¥23.23 Million | ▲ +6.4% |
| 2015 | CN¥723.81 Million | CN¥756.00 Million | CN¥32.19 Million | ▲ +3.9% |
| 2014 | CN¥696.53 Million | CN¥741.13 Million | CN¥44.60 Million | ▲ +3.9% |
| 2013 | CN¥670.29 Million | CN¥703.99 Million | CN¥33.70 Million | ▲ +4.6% |
| 2012 | CN¥640.90 Million | CN¥667.61 Million | CN¥26.72 Million | ▲ +4.8% |
| 2011 | CN¥611.46 Million | CN¥633.82 Million | CN¥22.37 Million | ▲ +7.0% |
| 2010 | CN¥571.30 Million | CN¥587.42 Million | CN¥16.12 Million | ▲ +464.2% |
| 2009 | CN¥101.26 Million | CN¥136.30 Million | CN¥35.04 Million | ▲ +73.5% |
| 2008 | CN¥58.36 Million | CN¥86.93 Million | CN¥28.57 Million | ▲ +140.6% |
| 2007 | CN¥24.25 Million | CN¥67.79 Million | CN¥43.53 Million | — |